On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Tube Pharmaceuticals GmbH's own share of each project, not the project's full budget.
- FP7 (2007 to 2013)€277k · 1 project
Projects
1 EU-funded project, newest first. Each links to the official record.
- MABTOXPartner
Generation and Evaluation of ""Next-generation"" Antibody-Toxin-Conjugates for Cancer Therapy""
FP7 (2007 to 2013) · 2013–2015 · Project on CORDIS ↗
€277ktheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- Westfaelische Wilhelms-Universitaet MuensterGermany · 1 shared project
- Charles River Discovery Research Services Germany GmbHGermany · 1 shared project
- Biomedal SLSpain · 1 shared project
- Nbe-Therapeutics AGSwitzerland · 1 shared project
- Jpt Peptide Technologies GmbHGermany · 1 shared project
- Era BiotechSpain · 1 shared project
- Zera Intein Protein Solutions SLSpain · 1 shared project
- Protagen Protein Services GmbHGermany · 1 shared project
- Evitria AGSwitzerland · 1 shared project
- Inno Tune BvbaBelgium · 1 shared project
- Tbd-Biodiscovery OuEstonia · 1 shared project
Fields it works in
Research fields recorded on its Horizon projects.
- genetics
- oncology
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗